Baxdrostat fits the hypertension type most common in Black adults. Its trial cannot say whether it works for them.
The Food and Drug Administration approved baxdrostat, sold as Baxfendy, on May 15, 2026, the first aldosterone synthase …
Black Health Editorial team
11m
